共 24 条
[1]
Capeci C.M., Tejwani N.C., Bilateral low energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy, J Bone Joint Surg Am, 91, pp. 2556-2561, (2009)
[2]
Goh S.-K., Yang K.Y., Koh J.S.B., Wong M.K., Chua S.Y., Chua D.T.C., Howe T.S., Subtrochanteric insufficiency fractures in patients on alendronate therapy: A caution, Journal of Bone and Joint Surgery - Series B, 89, 3, pp. 349-353, (2007)
[3]
Neviaser A.S., Lane J.M., Lenart B.A., Edobor-Osula F., Lorich D.G., Low-energy femoral shaft fractures associated with alendronate use, Journal of Orthopaedic Trauma, 22, 5, pp. 346-350, (2008)
[4]
Odvina C.V., Zerwekh J.E., Rao D.S., Maalouf N., Gottschalk F.A., Pak C.Y.C., Severely suppressed bone turnover: A potential complication of alendronate therapy, Journal of Clinical Endocrinology and Metabolism, 90, 3, pp. 1294-1301, (2005)
[5]
Cheung R.K.H., Leung K.K., Lee K.C., Chow T.C., Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate, Hong Kong Medical Journal, 13, 6, pp. 485-489, (2007)
[6]
Lenart B.A., Neviaser A.S., Lyman S., Chang C.C., Edobor-Osula F., Steele B., Van Der Meulen M.C., Lorich D.G., Lane J.M., Association of low-energy femoral fractures with prolonged bisphosphonate use: A case control study, Oseoporosis Int, 20, pp. 1353-1362, (2009)
[7]
Ing-Lorenzini K., Desmeules J., Plachta O., Suva D., Dayer P., Peter R., Low-energy femoral fractures associated with the long-term use of bisphosphonates: A case series from a Swiss university hospital, Drug Saf, 32, pp. 775-785, (2009)
[8]
Tonino R.P., Meunier P.J., Emkey R., Rodriquez-Portales J.A., Menkes C.J., Wasnich R.D., Bone H.G., Santora A.C., Wu M., Desai R., Ross P.D., Skeletal benefits of alendronate: 7 year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group, J Clin Endocrinol Metab, 85, 9, pp. 3109-3115, (2000)
[9]
Mashiba T., Turner C.H., Hirano T., Forwood M.R., Johnston C.C., Burr D.B., Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles, Bone, 28, 5, pp. 524-531, (2001)
[10]
Mashiba T., Hirano T., Turner C.H., Forwood M.R., Johnston C.C., Burr D.B., Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib, Journal of Bone and Mineral Research, 15, 4, pp. 613-620, (2000)

